✦ LIBER ✦
Long-term outcome of intravitreal anti-vascular endothelial growth factor therapy with bevacizumab or ranibizumab as primary treatment for subfoveal myopic choroidal neovascularization
✍ Scribed by Lai, T Y Y; Luk, F O J; Lee, G K Y; Lam, D S C
- Book ID
- 127022750
- Publisher
- Nature Publishing Group
- Year
- 2012
- Tongue
- English
- Weight
- 455 KB
- Volume
- 26
- Category
- Article
- ISSN
- 0950-222X
No coin nor oath required. For personal study only.